summary 1. A colorimetric method was developed for the direct chemical assay of human carboxypeptidase A (carboxypolypeptidase; EC 3.4.12.2) with angiotensin converting enryme-like activity in serum or plasma, with the ,u&trate analogue glycyl-Lhistidylglycine and the angiotensinmnverting enzyme substrate angiotensin I (A-I). This method was based on the spectrophototometric determination of histidylglycine and histidyl-leucine, products of the hydrolysis of glycyl-L-histidylglycine and A-I respectively. o-PhthJaldehyde reacted with the imidazole moiety of N-terminal histidyl peptides to produce a yellow chromophore.
Introduction
For many years, the assay of the components of the renin-angiotensin system solely depended upon the pressor response of angiotensin I1 in animals. Very few methods were available for the direct chemical assay of angiotensin converting enzyme, an enzyme capable of hydrolysing thd decapeptide A W ) to the vasoactive octapeptide A-I1 (Boucher, Kurihara, Grise & Genest, 1970) . The first synthetic substrates for angiotensin converting enzyme, benzoylglycylglycylglycine and benzoylglycylhistidyl-leucine, were cleaved rather slowly compared with A-I. The site of enzymic action was the peptide bond to which glycine or histidine contributed the NH group.
A decisive advance was made by Piquilloud, Reinhard & Roth (1970) , who showed that shortening the peptide chain of A-I from the amino end to form benzyloxycarbonyl-Phe-His-Leu does not abolish the susceptibility to the converting enzyme. Since 1969, studies have shown that the action of angiotensin converting enzyme on short synthetic peptides could involve the cleavage of many kinds of peptide bonds and can be considered an enzyme of rather broad side-chain specificity (Cushman & Cheung, 1971 ; Yang, Erdos & Levin, 1970; Stevens, Micalizzi, Fessler &Pals, 1972) .
Since the natural substrate A-I is very expensive and radioimmunoassay and bioassay methods are expensive, time-consuming and technically involved, an inexpensive substrate was sought whose hydrolytic products were more easily measured. Thus, described here is a simple, sensitive and direct colorimetric method for the assay of human plasma carboxypeptidase A (carboxypolypeptidase ; EC 3.4.12.2), with angiotensin converting enzyme-like activity, using Gly-His-Gly as substrate. Human plasma or serum hydrolysed the tripeptide Gly-HisGly, liberating glycine and the dipeptide histidylglycine. o-Phthalaldehyde reacted with the imidazole moiety of the N-terminal histidyl peptide to produce a yellow chromophore. Similarly, Piquilloud et al. (1970) utilized A-I and the substrate analogues benzyloxycarbonyl-Phe-His-Leu and benzyloxycarbonylPro-Phe-His-Leu and fluorimetrically determined the hydrolytic product His-Leu with o-phthalaldehyde.
Several compounds previously reported as converting enzyme inhibitors similarly inhibited carboxypolypeptidase activity with Gly-His-Gly as substrate, e.g. histidyl-leucine, A-11, EDTA, 8-hydroxyquinoline and Bothrops jararaca venom extract.
Spectrophotometric methods were later developed for assaying partially purified preparations of angiotensin converting enzyme, using the substrate analogues hippuryl-His-Leu (Cushman & Cheung, 1971 ) and hippuryl-Gly-Gly (Yang et al., 1970) and their nitrated analogues (Stevens et al., 1972) .
Methods
o-Phthalaldehyde, all the small L-peptides, including glycyl-L-histidylglycine, and Bothrops jararaca venom were purchased from Sigma Chemical Corporation. A-I (Asp', Iles) and A-I1 (Asp', Iles) were purchased from Schwartz-Mann. All experiments were done with human plasma or human serum.
Extinction of the samples was measured with a Gilford recording spectrophotometer, model 2400S, attached to a Honeywell recorder.
Human plasma angiotensin converting enzyme activity
Spectrophotometric assay. To 0.2 ml of 1.0 mmol/l A-I or Gly-His-Gly was added 10 pl of serum or plasma. The mixture then was incubated at 37°C for 10 rnin with Gly-His-Gly as substrate, or for 120 min when A-I was used, and the enzymic reaction terminated by the sequential addition of 50 p1 of 0.67 mol/l sulphuric acid, 20 PI of 100 g/l sodium tungstate, and 0.32 ml of water. The tungstic acidprecipitated serum or plasma proteins were removed by centrifugation in an International model H Clinical Centrifuge at 4000 rev./min for 5-10 min. Into a 0.40 ml aliquot of the protein-free atrate was pipetted 0.60 ml of 2 moll1 potassium hydroxide followed by 0.10 ml of o-phthalaldehyde (10 g/l in ethanol). The extinction of the test solution and the reagent blank was measured in 1.0 cm quartz cuvettes at 420 nm 5 min after the addition of the reagent. The net extinction of the test solution after blank correction was compared with a His-Gly (Gly-His-Gly as substrate) or His-Leu (A-I as substrate) standard curve in order to ascertain the amount of dipeptide liberated during the 10 min or 120 min incubation period. The His-Gly and His-Leu standard solutions should be prepared daily.
Enzyme units. One unit of angiotensin converting enzyme activity is defined as that amount of enzyme which hydrolysed 1 nmol of Gly-His-Gly per 10 rnin at 37°C under the conditions described above.
Electrophoresis of proteins in polyacrylamide gels
The separating gel, containing acrylamide (70 g/l) and bisacrylamide (2-1 g/l) in Tris buffer (03 mol/l), was adjusted to pH 8.8 with 0.1 mol/l hydrochloric acid and addition of 60 pl of ammonium persulphate (50 g/l) and 20 pl of NNNN-tetramethylenediamine. After mixing, the gel was poured into the glass tubes, carefully covered with a little water, and allowed to set 2G30 min.
After polymerization, the tubes were inserted into the ISCO model 419 electrophoresis apparatus and pre-electrophoresed at 3 mA current per tube for 30 min. The upper and lower buffer reservoirs contained borate buffer (0.05 mol/l) adjusted to pH 9.2 with sodium hydroxide (1 .O mol/l). After pre-electrophoresis, 10 of protein sample (serum diluted 1 : 2 with 200 g/l sucrose containing Bromophenol Blue as the tracking front) was carefully layered on the gel surface by use of a 10 ,ul pipette with mouthpiece. A 3 mA current was applied to each tube until the Bromophenol Blue tracking front migrated to the bottom of the gel tube (45 min).
The gels were carefully extruded by inserting between the gel and glass tube wall a 22-gauge needle attached to the hypodermic syringe filled with water to provide lubrication, They were then cross-sectioned with a razor blade every 1 cm in order to locate angiotensin converting enzyme activity. The gel sections were triturated with a stirring rod and macerated for 48 h in 0.6 ml of Na2HP04 buffer (0.05 mol/l) adjusted to pH 7.25 with hydrochloric acid (1.0 mol/l) containing sodium chloride (0.1 mol/l) and the substrate (A-I, 200 nmol; Gly-His-Gly, 200 nmol) at 4°C. The mixtures were incubated for 2 h at 37°C and assayed spectrophotometricaliy.
Thin-layer chromatography
Thin-layer chromatography was employed to identify the lytic products of the substrate. Theincubation mixtures were evaporated to dryness in 10 ml beakers at 65°C after preincubation of the substrate with saline-dialysed serum. The residues were redissolved in a smallvolume of water. The aqueous mixture was applied to thin-layer chromatography plates of silica gel and developed with acetone/water/acetic acid/ formic acid (70: 20: 8 : 2) as the migrating solution.
Bothrops jararaca venom extract
Bothrops jararaca pit viper venom (5 mg) was extracted by the addition of 1 ml of ethanol, allowed to stand at 37°C for 48 h, and centrifuged to remove turbidity. The crude ethanolic extract, containing peptide inhibitors, was used directly in the assay.
Inhibitor studies
Some compounds may react with o-phthalaldehyde or the o-phthalaldehyde-His-Gly adduct, diminishing or enhancing the yellow colour intensity. To eliminate the inhibitor concentration effects which might have occurred by interaction with the chromophore or o-phthalaldehyde, the same amount of inhibitor was added to the control tubes after incubation of the enzyme with substrate. Since the snake venom extract was dissolved in ethanol, an equivalent amount of ethanol was added to every tube in order to eliminate any inhibitory effect that the ethanol may have had on the enzyme.
The enzyme effectors were preincubated for 30 min at 37°C with the serum before initiating the reaction with substrate.
Influence of anions
Chloride-free phosphate buffer was prepared by dissolving 7.1 g of anhydrous disodium hydrogen phosphate in distilled and deionized water, titrating to pH 7.25 with phosphoric acid and diluting to 1 litre with water. Serum was dialysed overnight against the buffer to render it chloride-free. The substrate Gly-His-Gly was prepared as previously described, except that chloride-free buffer was used. An aliquot of the dialysed serum, substrate containing chloride ion (0.2 mol/l) being used as a control, was assayed for angiotensin converting enzyme activity.
Results

Method of assay
The spectrophotometric method developed for the assay of angiotensin converting enzyme was particularly suitable since the substrate analogue GlyHis-Gly is commercially available and hydrolysed more rapidly than the natural substrate A-I, thus permitting a short incubation time. The formation of the yellow colour upon reaction of o-phthalaldehyde at alkaline pH with the imidazole group of histidyl dipeptides allowed both His-Gly and His-Leu to be determined spectrophotometrically. The histidine must be the N-terminal amino acid for the reaction with o-phthalaldehyde.
The extinction of the His-Gly (6 = 667) and HisLeu (e = 800) 0-phthalaldehyde adducts at 420 nm was a linear function of the His-Gly or His-Leu concentration over the range investigated, demonstrating a strict adherence to the Beer-Lambert law. No deviation was observed for either dipeptide when assay concentrations of up to 0.2 mmol/l were employed. The colour due to the His-Gly o-phthalaldehyde adduct was stable 5-10 rnin after the addition of o-phthalaldehyde. The colour slowly decays after the 10 min period.
The hydrolysis of Gly-His-Gly was found to be proportional to the time of incubation at fixed enzyme concentration and substrate concentration (Fig. 1) . 
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The hydrolysis of Gly-His-Gly was proportional to the protein concentration of the serum. The velocity of the enzyme reaction characteristically increased with increasing concentration of Gly-His-Gly (Fig. 2) , and the Lineweaver-Burke plot (Fig. 2, inset) The temperature optimum was 4244°C when Gly-His-Gly was incubated with the enzyme. In addition, incubation in 0.05 mol/l phosphate buffer (the pH was adjusted with hydrochloric acid between 7 and 9 by titration) showed a pH optimum at 7.25. This agrees with the value of 7.25 reported by Huggins, Corcoran, Gordon, Henry & John (1970) for plasma angiotensin converting enzyme.
The colorimetric determination of the liberated His-Gly from the catalysed hydrolysis of Gly-HisGly by serum angiotensin converting enzyme was sensitive for use with small volumes of serum. However, removal of serum proteins was necessary since the amber colour of serum, similar in colour to the His-Gly chromophore, absorbed at 420 nm. Protein removal by tungstic acid prevented the reaction of o-phthalaldehyde with proteins, thus reducing the background colour to an almost negligible level and permitting measurement of His-Gly in nmol quantities.
Reproducibility of the method, assessed by calculating the standard deviation from the mean of repeated assays during 30 consecutive days on freezedried control serum, was found to give a mean value of 11.7 units, SD of 1.1 units, and a coefficient of variation of 9.8%.
The normal range (95% confidence limits) for twenty-nine females (randomly selected from hospital and clinic population) and thirty-seven healthy males (selected after annual physical examination) was 22-28 and 20-24 angiotensin converting enzyme units respectively. The difference was not statistically significant (t-test); thus the normal range for the entire population was 10-37 units ( f 2 SD from the mean). 
Polyacrylamide gel electrophoresL
Serum angiotensin converting enzyme was revealed by incubating the gel sections with Gly-His-Gly and A-I, changing the liberated dipeptides with o-phthalaldehyde, and measuring the extinction at 420 nm. Activity was found to occur in several sections after polyacrylamide gel electrophoresis. Table 1 summarizes a number of compounds that were tested as carboxypolypeptidase inhibitors in order to determine whether inhibitors of A-I hydrolysis also affected Gly-His-Gly hydrolysis. Since converting enzyme requires a bivalent metal ion for activity, incubation with 0.2 mmol/l EDTA similarly by polyacrylamide gel sections. Serum was applied to the gels, polymerized at pH 8.8 with Tris buffer (0.3 mol/l) and immersed in 0.05 moll1 borate electrode buffer, pH 9-2, and 3 mA current applied to each tube for approx. 45 min. The gels were cut into six 1 cm sections, incubated with substrate (ZOO nmol) and the liberated dipeptides were quantified colorimetrically with o-phthalaldehyde at 420 nm. Serum was preincubated for 30 min at 37' C with the effector and the reaction initiated by the addition of 100 nmol of Gly:His-Gly. The samples were assayed spectrophotometrically as described in the text.
Inhibitors
Enzymic effector Inhibition
(%) definitively demonstrate that when the ratio of GlyHis-Gly to A-I is 2:1, 64% inhibition i s produced. Product inhibition also occurred: His-Leu (Fig. 5 
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reaction at 0.1 mmol/l, suggesting that both peptides are competing for the active site of converting enzyme. Secondly, the cleavage products of A-I hydrolysis, A-I1 and His-Leu, greatly inhibited the hydrolysis of Gly-His-Gly, with 50% inhibition occurring at 0.08 mmol/l for His-Leu and 0.075 mmol/l for A-11. Thirdly, since converting enzyme required a bivalent metal ion for activity, incubation of the Gly-His-Gly with 0.2 mmol/l EDTA and 2.5 mmol/l 8-hydroxyquinoline produced inhibition. In addition, all other studies have shown that Gly-HisGly is inhibited by the same agents which affect the hydrolysis of A-I, including the ethanolic extract of Bothrops jararaca, which is a specific inhibitor of angiotensin converting enzyme (Greene, Camargo, Krieger, Stewart & Ferreira, 1972) . Several investigators have reported that chloride ion stimulated the hydrolysis of A-I by converting enzyme, whereas in this study the hydrolysis of Gly-His-Gly is independent of the concentration of chloride ion. Oparil, Koerner, Tregear, Barnes & Haber (1973) have elegantly demonstrated, using D-amino acid enantiomorphs of A-I, that the enzymic binding sites for the decapeptide A-I extended from positions 8 to 10, and Gly-His-Gly is probably bound at the same region of this active site. However, the chloride ion may be exerting its activator effect at positions 1 to 7, which are removed from the curbay-terminal site.
Finally, hydrolysis of A-I and Gly-His-Gly by the same polyacrylamide gel electrophoresis regions led to the conclusion that Gly-His-Gly is hydrolysed by the same enzyme that catalysed the cleavage of A-I. 
Univalent anion
Studies have shown that chloride ion enhances converting enzyme activity with certain substrates (Skeggs, Marsh, Kahn & Shumway, 1954; Piquilloud et al., 1970; Cushman & Cheung, 1971) . The enzymic effect on the hydrolysis of Gly-His-Gly was independent of the chloride ion concentration since the activity was identical in the presence or absence of chloride ion.
Discussion
Gly-His-Gly proved to be an excellent substrate analogue for a routine assay procedure because of the rapid rate of hydrolysis of Gly-His-Gly and the small number of reagents required. Experiments were then undertaken to demonstrate that the hydrolysis of Gly-His-Gly was being catalysed by angiotensin converting enzyme. The following evidence strongly supports the conclusion that the conversion of A-I into A-I1 and the hydrolysis of Gly-His-Gly are catalysed by the same enzyme. First, if Gly-His-Gly is actually a converting enzyme substrate, then the hydrolysis of this substrate should be inhibited by increasing concentrations of A-I. As can be seen in Fig. 4 , A-I is a strong inhibitor of the hydrolytic
